Clinical TrialHighlightedHydrogen inhalation positively affects cardiometabolic risk factors in men and women aged 65 years or older: a preliminary reportMHID-0517534PMID: 346542212018European Geriatric MedicineDarinka Korovljev, Valdemar Stajer, Dejan Javorac, Sergej M OstojicMolecular hydrogen (H2) has been recently introduced as an experimental medical gas in clinical medicine [1]. Beneficial effects of H2 are attributed to its antioxidant, anti-apoptotic and anti-inflammatory properties, with H2 administered via oral, parenteral or inhalational route found beneficial in cardiometabolic disorders [2]. However, no information is currently available concerning its effi